Nov 06 (Reuters) - Organogenesis Q3 adjusted EBITDA USD 30.1 million.
- Q3 adjusted net income USD 23.2 million
- Q3 net income USD 21.6 million
- Q3 operating income USD 20.7 million
- outlook FY net income USD 8.6-25.4 million
- outlook FY EBITDA USD 19.1-41.9 million
- outlook FY adjusted EBITDA USD 45.5-68.3 million
- outlook FY adjusted net income USD 21.5-38.4 million